It’s Still All About Relationships: Why Sponsors, CROs, Patients, and Study Sites Are Key to Improving Performance

By Jeff Zucker, M.S., Senior Vice President, Clinical Operations and Trial Optimization,

Throughout the clinical trial industry, stakeholders are embracing the value of patient centricity in the execution of drug development research and in understanding real-world marketability. Recognizing the role of sites and investigators in supporting patient-focused studies, Jeff Zucker identifies six areas in which CROs might nurture site relations.

Read More

Dementia Research: The Potential of Nrf2 in CNS Research

doctor reviewing patient brain scan
By Tomislav Babic, Vice-President Scientific Solutions,

  In recent years, research in the field of dementia has been exploring the role of Nrf2 in the body and uncovering its potential for antioxidant, anti-inflammatory, and mitochondrial functions.[i] Of particular interest is its role in the central nervous system (CNS) and on the aging brain. The following is a roundup of the most current knowledge about Nrf2 and its role in prominent degenerative conditions.

Read More